We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




PACS Company Honored by Award

By HospiMedica staff writers
Posted on 09 Nov 2005
Print article
Heartlab (Westerly, RI, USA), an Agfa (Mortsel, Belgium) company, recently announced a 2005 Business Development Leadership Award from Frost & Sullivan (Palo Alto, CA, USA), the international growth consultancy company.

The award recognizes Heartlab's ability to perceive and meet consumer needs by successfully developing and introducing products and services and by identifying new market segments to expand the existing customer base.

"In the intensely competitive U.S. cardiology PACS [picture archiving and communication systems] environment, Heartlab has consistently anticipated and met the needs of the marketplace,” said Katherine Shariq, senior industry analyst at Frost & Sullivan. "Heartlab's rigorous and ongoing analysis of customer needs and its continuous development and adoption of state-of-the-art analytics, network, storage, and IS [information system] integration solutions enables it to meet the future needs of its expanding customer base.”

Moreover, Frost & Sullivan's 2005 survey of the U.S. cardiology (PACS) market showed Heartlab as the third largest provider of cardiology PACS solutions in the United States in 2004. With 17.8% for direct sales and 2.5% for indirect original equipment manufacturer (OEM) sales (through its parent company, Agfa), Heartlab has increased its share of the US$166 million U.S. market by more than 8% from 2002, the last year that Frost & Sullivan surveyed the market.

"As the market continues to evolve, Heartlab has emerged as the only viable modality independent solution provider for Cardiology information systems,” said Robert Petrocelli, Heartlab's CEO.





Related Links:
Agfa
Frost & Sullivan
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Wound Care Cart
UMGKA-3669-LTG
New
Dry Thawing & Warming System
SAHARA-TSC 230 V

Print article

Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.